Enhanced production of immunoglobulins

a technology of immunoglobulin and immunoglobulin, which is applied in the direction of peptides, fused cells, genetically modified cells, etc., can solve the problems of inability to pre-select only the antigen-specific, unable to work well as selection methods based on the cell surface expression of antigen receptors, magnetic or flow-cytometric sorting, etc., to achieve enhanced identification efficiency and immunoglobulin specificity , the effect of determining the specifi

Pending Publication Date: 2021-09-23
TRIANNI INC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention provides a way to determine the specificity of immunoglobulin molecules using existing techniques such as binding to fluorescently labeled antigen and flow cytometric or microscopic procedures. This allows for the efficient identification and isolation of rare antigen-specific cells and the cloning of the rearranged immunoglobulin genes from the isolated cells. The patent also describes the use of DNA vectors to express immunoglobulin-capturing molecules on the surface of bare or immunoglobulin-containing cells, and the binding of labeled antigens to these molecules. Overall, the invention provides a method for studying the function and specificity of immunoglobulin molecules in a more efficient and precise way.

Problems solved by technology

Despite the eventual success in producing monoclonal antibodies against the antigen of interest using either hybridoma or single-cell cloning technique, the efficiency of both techniques is hampered by the labor-intensive process of screening and selection.
This is because it has not been feasible to pre-select only the antigen-specific ASCs for fusion with myeloma cells or for single-cell cloning.
Thus, selection methods based on the cell surface expression of antigen receptors, such as magnetic or flow-cytometric sorting, do not work well as tools to select for antigen-specific ASCs.
Due to this lack of ability to pre-select ASCs, only a small fraction of cells screened in both hybridoma and single-cell cloning techniques produces monoclonal antibodies with specificity for the antigen of interest.
Moreover, the specified methods do not provide a strategy to increase the efficiency of monoclonal antibody generation using direct VH and VL cloning technique from sorted single cells.
Re-introduction of CD79A and CD79B expression by ASCs in vivo may not provide a viable strategy to increase the expression of antigen receptors on the cell surface either.
Finally, expressing CD79A and CD79B on ASCs ex vivo to circumvent the aforementioned problems associated with their enforced expression in vivo is not a practical strategy because ASCs are not amenable to gene transfer by most methods currently available.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enhanced production of immunoglobulins
  • Enhanced production of immunoglobulins
  • Enhanced production of immunoglobulins

Examples

Experimental program
Comparison scheme
Effect test

example 1

n of a Minimal Protein G-Containing Membrane-Bound Immunoglobulin-Capturing Molecule

[0076]An expression vector encoding a small membrane-bound form of the immunoglobulin-capturing molecule without a stalk is generated by direct DNA synthesis or standard molecular cloning techniques. A diagram of the protein-coding part of this vector (501) is shown in FIG. 5A. The expression vector encodes two immunoglobulin-binding domains of streptococcal Protein G (504) [SEQ ID No. 8] that are tethered to the cell surface by means of a membrane-spanning domain derived the human LAG3 (or CD223) protein (506) [SEQ ID No. 17]. A fragment of DNA encoding a short linker consisting of Gly-Ser-Gly-Ser-Gly-Ser sequence (505) [SEQ ID No. 28] is placed between the DNA fragments encoding the Protein G immunoglobulin-binding domains (504) and the transmembrane domain (506) to provide structural flexibility to the expressed protein. Finally, a sequence encoding a signal peptide (leader peptide) (503) is inclu...

example 2

n of a Protein G-Containing Membrane-Bound Immunoglobulin-Capturing Molecule Containing a Stalk

[0080]An expression vector encoding a membrane-bound form of the immunoglobulin-capturing molecule containing a long stalk is generated by direct DNA synthesis or standard molecular cloning techniques. The expression vector encodes three immunoglobulin-binding domains derived from the C-terminal half of streptococcal Protein G [SEQ ID No. 9]. DNA fragments encoding a short linker consisting of Gly-Ser-Gly-Ser-Gly-Ser [SEQ ID No. 28] sequence, a stalk consisting of six immunoglobulin domains derived from human CD22 protein [SEQ ID No. 16], and a transmembrane domain derived from human CD58 [SEQ ID No. 18] are appended to the immunoglobulin-binding domain-encoding DNA fragment of the vector. Finally, a sequence encoding a signal peptide (leader peptide) is placed preceding the entire open-reading frame of the immunoglobulin-capturing molecule to allow for extrusion of the translated protein ...

example 3

n of a Protein G-Containing Immunoglobulin-Capturing Molecule Anchored to the Membrane by a GPI Post-Translational Modification

[0083]An expression vector encoding two immunoglobulin-binding domains derived from the streptococcal Protein G is synthesized. Included in this expression vector downstream of the Protein G-encoding sequence are DNA fragments that encode the following: a Gly / Ser-rich linker sequence, a stalk consisting of two immunoglobulin domains of human CD4, and a GPI anchor sequence. Finally, a signal peptide sequence (leader sequence) is included in the construct to allow for extrusion of the translated protein into the lumen of the endoplasmic reticulum during its biosynthesis. The sequences encoding the signal peptide in this example are derived from an immunoglobulin light chain variable (VL) gene segment and include its native intron. The nucleotide and amino acid sequences of components comprising the immunoglobulin-capturing molecule in this example are specifie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods and compositions for generating transgenic animals, including transgenic mammals, as well as plasma cells that allow for cell surface capture of secreted immunoglobulin molecules produced endogenously in the plasma cells.

Description

RELATED APPLICATION[0001]This application claims priority to U.S. Ser. No. 62 / 291,217, filed Feb. 4, 2016.FIELD OF THE INVENTION[0002]This invention relates to production of immunoglobulin molecules, including methods for rapid screening of antigen-specific antibody-secreting cells for the generation of monoclonal antibodies.BACKGROUND OF THE INVENTION[0003]In the following discussion certain articles and methods are described for background and introductory purposes. Nothing contained herein is to be construed as an “admission” of prior art. Applicant expressly reserves the right to demonstrate, where appropriate, that the articles and methods referenced herein do not constitute prior art under the applicable statutory provisions.[0004]Monoclonal antibodies are important biologics that have been widely employed in biomedical research, in clinical diagnostics, and as therapeutic agents because of their exquisite ability to bind antigens of diverse molecular forms. In drug developmen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07K14/315C07K16/00C07K14/705C07K14/73C07K14/74C12N5/0781C12N5/12C12N5/16A01K67/027C07K16/42
CPCC07K14/315A01K2217/072C07K14/70503C07K14/70596C07K14/70514C07K14/70539C12N5/0635C12N5/12C12N5/16A01K67/0278C07K16/42C07K2317/14C07K2319/03C07K2319/02C07K2317/622A01K2267/01A01K2227/105C12N2510/02C07K16/00C07K14/31C07K2319/00C07K14/705
InventorKILLEEN, NIGELHASENHINDL, CHRISTOPHDUONG, BAO
OwnerTRIANNI INC